Loading
Latest filing published 17 Apr 2026 for Lixte Biotechnology Holdings, INC..
No signal scores available.
Only one filing by Michael Andrew Holloway is known so far (17 April 2026): a share grant, in Lixte Biotechnology Holdings, Inc. That is too little to draw conclusions. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration